acne

A new study suggests that some lesser-known cannabinoids in hemp and marijuana can help with common skin conditions like psoriasis, eczema and acne. A study published by the journal 'Molecules' aptly notes, “Dermatological diseases pose a significant burden on the...

Brookline has initiated Dermata Therapeutics Inc's (NASDAQ: DRMA) coverage with a Buy rating and $14 price target. Analyst Kumaraguru Raja sees an upside of almost 164%. Dermata's pipeline includes DMT310, a once-weekly topical product for acne, psoriasis & rosacea, and...

Foamix Pharmaceuticals Ltd (NASDAQ: FOMX) shares were solidly higher Wednesday on positive trial results for its acne treatment candidate. Biopharmx Corp (NYSE: BPMX), which also has an acne product candidate in development, moved in sympathy, although it was trading down at the time of...

Despite having hit its primary endpoint in the Phase 2b clinical trial of acne-treating BPX-01, Biopharmx Corp (NYSE: BPMX) plunged last week on a secondary endpoint miss on the Investigator’s Global Assessment (IGA) scale for acne severity. BioPharmX now looks to hit IGA goals as a coprimary...

Biopharmx Corp (NYSE: BPMX) shares have moved 38 percent higher in 2017 as the company progresses its dermatology-centric drugs through the pipeline. The Silicon Valley-based pharmaceutical currently has its lead candidate, BPX-01, undergoing both a Phase 2b dose finding trial for the treatment of...